Executive Search Success Story: Scaling Global Leadership for a Specialty Pharma Rare Disease Division
How JRG Partners built the commercial, market-access, and patient-services leadership team behind a global specialty pharmaceutical company’s rare disease division expansion — recruiting across eight leadership mandates through a confidential search.
Engagement Snapshot
| Client | Global specialty pharmaceutical company — rare disease business unit (name withheld) |
| Industry | Specialty Pharmaceuticals — Rare Disease — Global Commercial Leadership |
| Geography | Global (incl. Boston, New York, San Francisco, London, Paris, Basel, Munich, Singapore) |
| Engagement | Confidential executive search — multi-role leadership mandate |
| Role(s) Searched | President, Rare Disease Division; Global Commercial Leaders; VP Market Access; VP Patient Services; Regulatory Affairs Executives; Medical Affairs Leaders; International Business Development Executives; Regional General Managers |
| Talent Assessed | 550+ executive profiles evaluated globally |
| Timeline | Multiple placements completed within 12 months |
The Challenge
A global specialty pharmaceutical company was expanding its rare disease business unit through acquisitions, product launches, and international market expansion. While growth opportunities remained strong, leadership faced increasing challenges in recruiting executives capable of managing complex global operations and highly specialized therapeutic portfolios. Leadership identified several pressures:
- Growing competition for experienced rare disease commercial leaders
- Increasing demand for market access and reimbursement expertise
- Expansion into new international markets
- Need for stronger patient advocacy and stakeholder engagement strategies
- Succession concerns within key leadership roles
- Pressure to accelerate growth while maintaining regulatory compliance
The Board and executive leadership team determined that strategic executive recruitment would be necessary to support continued expansion. The confidential mandate covered a President of the Rare Disease Division, Global Commercial Leaders, VP Market Access, VP Patient Services, Regulatory Affairs Executives, Medical Affairs Leaders, International Business Development Executives, and Regional General Managers. The organization required a search partner with expertise in rare disease pharmaceuticals, specialty therapeutics, and global commercial leadership.
Why They Chose JRG Partners
After evaluating several executive search firms, the client selected JRG Partners for four reasons:
Specialized Rare Disease Recruitment Expertise
JRG Partners maintains dedicated executive search practices focused on specialty pharmaceuticals, rare disease therapies, biotechnology, and executive leadership recruitment.
Access to Elite Industry Talent
Many top-performing rare disease executives are not actively pursuing new opportunities. Through extensive industry relationships, JRG Partners identified exceptional candidates unavailable through traditional recruiting channels.
Deep Understanding of Global Rare Disease Markets
The client required leaders experienced in commercialization, reimbursement, patient advocacy, market access, and international expansion. Our recruiters understood these specialized competencies.
Global Recruitment Reach
The search required executive talent from major life sciences markets including Boston, New York, San Francisco, London, Paris, Basel, Munich, and Singapore.
Our Executive Search Strategy
Phase 1 — Leadership Assessment
Our consultants partnered with executive leadership to evaluate commercial-growth objectives, market-expansion plans, leadership-capability gaps, patient-engagement priorities, succession-planning risks, and future organizational requirements. Rather than recruiting solely for open positions, we developed leadership profiles aligned with long-term strategic objectives.
Phase 2 — Talent Mapping
JRG Partners conducted a comprehensive market-mapping initiative covering rare disease pharmaceutical companies, specialty therapeutics organizations, biotechnology firms, global pharmaceutical companies, orphan drug developers, patient-focused healthcare organizations, and international life sciences businesses. More than 550 executive profiles were evaluated globally.
Phase 3 — Executive Engagement
Using a targeted research-driven approach, our consultants engaged leaders with demonstrated success in rare disease commercialization, global product launches, market-access strategy, patient-advocacy initiatives, international expansion, regulatory compliance, business development, and revenue-growth acceleration. Only candidates with proven achievements and strong cultural alignment advanced.
Phase 4 — Assessment & Selection
Each finalist underwent extensive evaluation focused on rare disease industry expertise, commercial leadership capabilities, market-access experience, global business acumen, team-building effectiveness, stakeholder-management skills, cultural fit, and long-term retention potential.
Results Delivered
JRG Partners successfully completed multiple executive leadership placements within twelve months across the global commercial expansion mandate.
- Strengthened Commercial Leadership: The organization successfully filled critical leadership positions with experienced rare disease pharmaceutical executives.
- Accelerated Market Expansion: Newly onboarding international operational leaders successfully supported entering and launching into multiple new global markets.
- Enhanced Patient Engagement: Strategic hires optimized advocacy frameworks, successfully strengthening key partnerships and patient-support initiatives.
- Increased Revenue Growth: Commercial executives improved overall product performance and tracking capabilities, successfully maximizing multi-market penetration.
- Strong Executive Retention: Placed corporate leaders successfully brought durable stability and remained with the organization through critical high-growth phases.
- Increased Board Confidence: Strategic executive recruitment successfully reduced operational risk and positioned the platform for sustained, long-term growth.
Partner with JRG Partners
Specialty pharma companies scaling rare disease divisions globally need leaders who can drive market access, patient advocacy, and international expansion. JRG Partners helps rare disease, specialty therapeutics, and global pharmaceutical organizations identify, attract, and retain exceptional commercial and patient-services executives who deliver growth.
Planning a confidential rare disease commercial search? Connect with our rare disease & specialty pharma search experts to discuss your mandate.
Connect With Our Rare Disease & Specialty Pharma Commercial Search Experts